Furthermore, despite the absence of a clear association between HER2 status and chemotherapy responsiveness in its cohort, Kuyama et al. also reported a worsened prognosis in 23 patients with HER2 FISH-positive NSCLC who underwent radio-chemotherapy [88]. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.